Trexquant Investment LP lifted its holdings in shares of Stevanato Group S.p.A. (NYSE:STVN – Get Rating) by 364.1% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 49,404 shares of the company’s stock after acquiring an additional 38,760 shares during the quarter. Trexquant Investment LP’s holdings in Stevanato Group were worth $781,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently made changes to their positions in the business. JPMorgan Chase & Co. bought a new position in shares of Stevanato Group during the 2nd quarter worth approximately $673,000. Royce & Associates LP grew its holdings in Stevanato Group by 246.3% during the second quarter. Royce & Associates LP now owns 848,955 shares of the company’s stock valued at $13,422,000 after purchasing an additional 603,796 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. bought a new position in shares of Stevanato Group in the second quarter worth $696,000. Envestnet Asset Management Inc. raised its position in Stevanato Group by 14.6% during the second quarter. Envestnet Asset Management Inc. now owns 56,140 shares of the company’s stock valued at $888,000 after purchasing an additional 7,151 shares in the last quarter. Finally, Comerica Bank bought a new stake in Stevanato Group during the 2nd quarter valued at approximately $1,964,000. 10.26% of the stock is currently owned by institutional investors.
Stevanato Group Price Performance
Shares of STVN opened at €15.00 ($15.31) on Friday. The company’s fifty day moving average price is €16.61 and its 200-day moving average price is €16.38. Stevanato Group S.p.A. has a 1-year low of €13.35 ($13.62) and a 1-year high of €24.60 ($25.10). The company has a debt-to-equity ratio of 0.18, a current ratio of 2.00 and a quick ratio of 1.51. The firm has a market capitalization of $4.43 billion, a PE ratio of 25.86 and a beta of 0.99.
Analyst Ratings Changes
About Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines.
- Get a free copy of the StockNews.com research report on Stevanato Group (STVN)
- Three CBD Stocks to Dominate a Budding Industry
- Institutional Support for Analog Devices Remains High
- Salesforce Cuts Labor, Shows Strong Earnings Despite Challenges
- Is the 60/40 Portfolio Mix Still in Vogue?
- Microsoft Shares: Is it Time to Back Up the Truck?
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.